Genetic immunization by jet injection of targeted pDNA-coated nanoparticles

被引:44
作者
Mumper, RJ [1 ]
Cui, ZR [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA
关键词
DNA vaccine; microemulsion; beta-galactosidase; Mannan;
D O I
10.1016/S1046-2023(03)00138-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Genetic immunization strategies have largely focused on the use of "naked" plasmid DNA or the gene gun. However, there remains a clear need to further improve the efficiency and/or cost of potential DNA vaccines. The theoretical basis of our research is to rationally design genetic immunization methodologies for nanoparticle-based delivery systems of plasmid DNA, perhaps in combination with already commercially available needle-free devices, such as the Biojector 2000. These methodologies may both reduce the dose of pDNA required and enhance the breadth and depth of protective immune responses (i.e., humoral and cellular). The purpose of this article is to provide detailed experimental methods to (1) engineer and characterize pDNA-coated cationic nanoparticles (<100 nm) directly from oil-in-water microemulsion precursors and (2) enhance both the breadth and depth of immune responses after immunization of mice with pDNA-coated nanoparticles by different routes of administration, including intradermal, using a needle-free jet injection device. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:255 / 262
页数:8
相关论文
共 37 条
[1]   Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device [J].
Aguiar, JC ;
Hedstrom, RC ;
Rogers, WO ;
Charoenvit, Y ;
Sacci, JB ;
Lanar, DE ;
Majam, VF ;
Stout, RR ;
Hoffman, SL .
VACCINE, 2001, 20 (1-2) :275-280
[2]   Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines [J].
Anwer, K ;
Earle, KA ;
Shi, M ;
Wang, JJ ;
Mumper, RJ ;
Proctor, B ;
Jansa, K ;
Ledebur, HC ;
Davis, S ;
Eaglstein, W ;
Rolland, AP ;
Rolland, P .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :889-895
[3]  
BAIZER L, 2002, PHARM MANU PACK SPR, P96
[4]  
BINDLE R, 1994, VACCINE, V12, P483
[5]   Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines [J].
Boyer, JD ;
Cohen, AD ;
Vogt, S ;
Schumann, K ;
Nath, B ;
Ahn, L ;
Lacy, K ;
Bagarazzi, ML ;
Higgins, TJ ;
Baine, Y ;
Ciccarelli, RB ;
Ginsberg, RS ;
MacGregor, RR ;
Weiner, DB .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :476-483
[6]  
CLARK ML, 1965, J LAB CLIN MED, V66, P34
[7]  
Conry RM, 1999, CLIN CANCER RES, V5, P2330
[8]   Topical immunization using nanoengineered genetic vaccines [J].
Cui, Z ;
Mumper, RJ .
JOURNAL OF CONTROLLED RELEASE, 2002, 81 (1-2) :173-184
[9]   Novel ethanol-in-fluorocarbon microemulsions for topical genetic immunization [J].
Cui, ZG ;
Fountain, W ;
Clark, M ;
Jay, M ;
Mumper, RJ .
PHARMACEUTICAL RESEARCH, 2003, 20 (01) :16-23
[10]   Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device [J].
Cui, ZR ;
Baizer, L ;
Mumper, RJ .
JOURNAL OF BIOTECHNOLOGY, 2003, 102 (02) :105-115